1. Jonas A. 2000. Lecithin cholesterol acyltransferase. Biochim Biophys Acta 1529:245-256.
2. Calabresi L, Pisciotta L, Costantin A, Frigerio I, Eberini I, Alessandrini P, Arca M, Bon GB, Boscutti G, Busnach G, Frasca G, Gesualdo L, Gigante M, Lupattelli G, Montali A, Pizzolitto S, Rabbone I, Rolleri M, Ruotolo G, Sampietro T, Sessa A, Vaudo G, Cantafora A, Veglia F, Calandra S, Bertolini S, and Franceschini G. 2005. The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler Thromb Vasc Biol 25:1972-1978.
3. Calabresi L, Baldassarre D, Castelnuovo S, Conca P, Bocchi L, Candini C, Frigerio B, Amato M, Sirtori CR, Alessandrini P, Arca M, Boscutti G, Cattin L, Gesualdo L, Sampietro T, Vaudo G, Veglia F, Calandra S, Franceschini G. 2009. Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans. Circulation 120:628-635.
4. Norum KR, and Gjone E. 1967. Familial serum-cholesterol esterification failure. A new inborn error of metabolism. Biochim Biophys Acta 144:698-700.
5. Santamarina-Fojo S, Hoeg JM, Assmann G, and Brewer HBJr. 2001. Lecithin cholesterol acyltransferase deficiency and fish eye disease. In The Metabolic and Molecular Bases of Inherited Diseases. Scriver CR, Beaudet AL, Sly WS, and Valle D, editors. McGraw-Hill. New York. 2817-2833.
6. Carlson LA, and Philipson B. 1979. Fish-eye disease. A new familial condition with massive corneal opacities and dyslipoproteinaemia. Lancet 2:922-924.
Letture selezionate
Albers JJ, Bergelin RO, Adolphson JL, and Wahl PW. 1982. Population-based reference values for lecithin:cholesterol acyltransferase (LCAT). Atherosclerosis 43:369-379.
Ayyobi AF, McGladdery SH, Chan S, John Mancini GB, Hill JS, and Frohlich JJ. 2004. Lecithin: cholesterol acyltransferase (LCAT) deficiency and risk of vascular disease: 25 year follow-up. Atherosclerosis 177:361-366.
Azoulay M, Henry I, Tata F, Weil D, Grzeschik KH, Chaves ME, McIntyre N, Williamson R, Humphries SE, and Junien C. 1987. The structural gene for lecithin:cholesterol acyl transferase (LCAT) maps to 16q22. Ann Hum Genet 51:129-136.
Calabresi L, Favari E, Moleri E, Adorni MP, Pedrelli M, Costa S, Jessup W, Gelissen IC, Kovanen PT, Bernini F, Franceschini G. 2009 Functional LCAT is not required for macrophage cholesterol efflux to human serum. Atherosclerosis 204:141-146.
Calabresi L, Moleri E, and Franceschini G. 2006. LCAT deficiency: molecular genetics, lipid/lipoprotein phenotype and atherosclerosis. Future Lipidology 1:241-245.
Carlson LA. 1982. Fish eye disease: a new familial condition with massive corneal opacities and dyslipoproteinaemia. Eur J Clin Invest 12:41-53.
Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, and Hobbs HH. 2004. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305:869-872.
Hovingh GK, de Groot E, van der Steeg W, Boekholdt SM, Hutten BA, Kuivenhoven JA, and Kastelein JJ. 2005. Inherited disorders of HDL metabolism and atherosclerosis. Curr Opin Lipidol 16:139-145.
Kuivenhoven JA, Pritchard H, Hill J, Frohlich J, Assmann G, and Kastelein J. 1997. The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J Lipid Res 38:191-205.
Lambert G, Sakai N, Vaisman BL, Neufeld EB, Marteyn B, Chan CC, Paigen B, Lupia E, Thomas A, Striker LJ, Blanchette-Mackie J, Csako G, Brady JN, Costello R, Striker GE, Remaley AT, Brewer HBJr, and Santamarina-Fojo S. 2001. Analysis of glomerulosclerosis and atherosclerosis in lecithin:cholesterol acyltransferase-deficient mice. J Biol Chem 276:15090-15098.
McLean J, Fielding C, Drayna D, Dieplinger H, Baer B, Kohr W, Henzel W, and Lawn R. 1986. Cloning and expression of human lecithin-cholesterol acyltransferase cDNA. Proc Natl Acad Sci U S A 83:2335-2339.
Peelman F, Vinaimont N, Verhee A, Vanloo B, Verschelde JL, Labeur C, Seguret-Mace S, Duverger N, Hutchinson G, Vandekerckhove J, Tavernier J, and Rosseneu M. 1998. A proposed architecture for lecithin cholesterol acyl transferase (LCAT): identification of the catalytic triad and molecular modeling. Protein Sci 7:587-599.
Viestenz A, Schlotzer-Schrehardt U, Hofmann-Rummelt C, Seitz B, and Kuchle M. 2002. Histopathology of corneal changes in lecithin-cholesterol acyltransferase deficiency. Cornea 21:834-837.